Konstantinos Xynos - Nov 16, 2023 Form 4 Insider Report for Replimune Group, Inc. (REPL)

Role: Chief Medical Officer
Signature: /s/ Shawn Glidden, attorney-in-fact
Stock symbol: REPL
Transactions as of: Nov 16, 2023
Transactions value $: -$79,858
Form type: 4
Date filed: 11/17/2023, 08:01 PM
Previous filing: May 18, 2023
Next filing: Apr 3, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	REPL	Common Stock	Sale	-$79.9K	-7.31K	-6.09%	$10.92	113K	Nov 16, 2023	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person.
F2	The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.92 to $11.09. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.

Content

Represents shares of the Issuer's common stock sold to cover tax withholding obligations in connection with the partial vesting of the Reporting Person's Restricted Stock Units ("RSU"). The transaction reported herein was made in accordance with the irrevocable "sell to cover" provision set forth in the award agreement under which the RSU was granted and does not represent a discretionary sale by the Reporting Person.

The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.92 to $11.09. The Reporting Person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.